A New 1,8-Naphthyridine-Pivalamide Hybrid: Synthesis, Structural Elucidation, Hirshfeld Surface Analysis, DFT study, ADME Analysis and Molecular Docking Studies against EGFR and CDK6
Authors:
- Indrajit SahaISIndrajit Saha
- Tanushree SenTSTanushree Sen
- Nabajyoti BaildyaNBNabajyoti Baildya
- Raymond J. ButcherRBRaymond J. Butcher
- Muhammad AshfaqMAMuhammad Ashfaq
- Muhammad LatifMuhammad Latif
- Necmi DegeNDNecmi Dege
- Sudhan DebnathSDSudhan Debnath
- Suman AdhikariSASuman Adhikari
- Kumaresh GhoshKGKumaresh Ghosh
- 19 February 2026
- journal article
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 26 (01) , 1-16
Abstract
This investigation focuses on the design, synthesis, comprehensive analysis and binding affinity with the epidermal growth factor receptor (EGFR), Cyclin-Dependent Kinase 6 (CDK6) of a new 1,8-naphthyridine-pivalamide hybrid 1. The newly synthesized 1,8-naphthyridine-pivalamide hybrid 1 was characterized by FT-IR, 1 H NMR, elemental analysis and single-crystal X-ray analysis. The crystal structure analysis disclosed that 1 is hydrated and supramolecular assembly is stabilized via O−H[ ]N, N−H[ ]O, and O−H[ ]O and off-set [ ] contacts. Various types of noncovalent contacts existing in the 1,8-naphthyridine-pivalamide hybrid 1 are explored, and subsequently quantified employing Hirshfeld surface analysis and 2D fingerprint plots. Furthermore, a void study was utilized to examine the mechanical stability and presence of the cavity within the solid-state structure of 1. The interaction energies between molecules in 1 have been investigated using the interaction energy calculation. Geometric parameters of the optimized structure of 1 were determined utilizing the DFT calculations. Furthermore, molecular docking studies indicated that the 1,8-naphthyridine-pivalamide hybrid 1 demonstrated promising binding affinity with EGFR and CDK6, compared to their known inhibitors. The newly synthesized 1,8-naphthyridine-pivalamide hybrid 1 also exhibited drug-likeness as predicted by SwissADME.Keywords
This publication has 58 references indexed in Scilit:
- Synthesis, Crystal Structure, Theoretical Analysis, Anticancer Properties, and Molecular Docking Study of a Dipyridyl Thiourea CompoundJournal of Heterocyclic Chemistry, 2025
- Medicinal Chemistry Perspective of 1,8‐Naphthyridines as Anticancer AgentsChemistry & Biodiversity, 2025
- Supramolecular Co (II) Complex Fabricated From Adenine Derivative: Synthesis, Crystal Structure, Hirshfeld Surface, DFT Optimization, Anticancer, and Molecular Docking StudiesApplied Organometallic Chemistry, 2024
- An Updated Review on Recent Advances in the Usage of Novel Therapeutic Peptides for Breast Cancer TreatmentInternational Journal of Peptide Research and Therapeutics, 2023
- Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profileBioorganic Chemistry, 2019
- Cyclin‐Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and FuturePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- 1,8‐Naphthyridine Derivatives: A Review of Multiple Biological ActivitiesArchiv der Pharmazie, 2015
- Synthesis, molecular docking of novel 1,8-naphthyridine derivatives and their cytotoxic activity against HepG2 cell linesMedicinal Chemistry Research, 2013
- Triptycene‐Derived Oxacalixarenes as New Wheels for the Synthesis of [2]Rotaxanes: Acid–Base‐ and Metal‐Ion‐Switchable Complexation ProcessesChemistry – A European Journal, 2011
- Hydrogen bonded assemblies of 1,8-naphthyridine derivatives: discrete or polymeric structures in the solid stateJournal of Inclusion Phenomena and Macrocyclic Chemistry, 2010